For persistent depression FDA approves a novel treatment based on ketamine - 0 views
-
RG Brown on 06 Mar 19For people with intractable depression, the FDA has approved a nasal spray called esketamine, which can take effect in hours, compared to weeks or months for traditional treatments. Esketamine is a component of ketamine, which has been used as a party drug.